141 related articles for article (PubMed ID: 28331341)
1. Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.
Guo W; Zheng Y; Xu B; Ma F; Li C; Zhang X; Wang Y; Chang X
Onco Targets Ther; 2017; 10():1475-1485. PubMed ID: 28331341
[TBL] [Abstract][Full Text] [Related]
2. PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.
Wang H; Xu B; Zhang X; Zheng Y; Zhao Y; Chang X
Cancer Cell Int; 2016; 16():61. PubMed ID: 27478411
[TBL] [Abstract][Full Text] [Related]
3. PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Zheng Y; Zhao G; Xu B; Liu C; Li C; Zhang X; Chang X
Oncotarget; 2016 Sep; 7(38):62159-62176. PubMed ID: 27556695
[TBL] [Abstract][Full Text] [Related]
4. Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.
Funayama R; Taniguchi H; Mizuma M; Fujishima F; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2017 Apr; 108(4):713-718. PubMed ID: 28403548
[TBL] [Abstract][Full Text] [Related]
5. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
6. Increased PADI4 expression in blood and tissues of patients with malignant tumors.
Chang X; Han J; Pang L; Zhao Y; Yang Y; Shen Z
BMC Cancer; 2009 Jan; 9():40. PubMed ID: 19183436
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Gao BS; Rong CS; Xu HM; Sun T; Hou J; Xu Y
Pathol Oncol Res; 2020 Apr; 26(2):1279-1285. PubMed ID: 31267364
[TBL] [Abstract][Full Text] [Related]
8. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminase 2 promotes T helper 17-like T cell activation and activated T cell-autonomous death (ACAD) through an endoplasmic reticulum stress and autophagy coupling mechanism.
Yang YF; Wang CM; Hsiao IH; Liu YL; Lin WH; Lin CL; Hung HC; Liu GY
Cell Mol Biol Lett; 2022 Mar; 27(1):19. PubMed ID: 35236296
[TBL] [Abstract][Full Text] [Related]
10. Investigating a pathogenic role for TXNDC5 in tumors.
Chang X; Xu B; Wang L; Wang Y; Wang Y; Yan S
Int J Oncol; 2013 Dec; 43(6):1871-84. PubMed ID: 24100949
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminase 2 plays a key role in osteogenesis by enhancing RUNX2 stability through citrullination.
Kim HJ; Shin HR; Yoon H; Park MS; Kim BG; Moon JI; Kim WJ; Park SG; Kim KT; Kim HN; Choi JY; Ryoo HM
Cell Death Dis; 2023 Aug; 14(8):576. PubMed ID: 37648716
[TBL] [Abstract][Full Text] [Related]
12. PADI2-Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1-Mediated SOX2 mRNA Stability in Endometrial Cancer.
Xue T; Liu X; Zhang M; E Q; Liu S; Zou M; Li Y; Ma Z; Han Y; Thompson P; Zhang X
Adv Sci (Weinh); 2021 Mar; 8(6):2002831. PubMed ID: 33747724
[TBL] [Abstract][Full Text] [Related]
13. Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.
Hsu PC; Liao YF; Lin CL; Lin WH; Liu GY; Hung HC
Mol Cells; 2014 May; 37(5):426-34. PubMed ID: 24850148
[TBL] [Abstract][Full Text] [Related]
14. PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.
Wang L; Song G; Zhang X; Feng T; Pan J; Chen W; Yang M; Bai X; Pang Y; Yu J; Han J; Han B
Cancer Res; 2017 Nov; 77(21):5755-5768. PubMed ID: 28819028
[TBL] [Abstract][Full Text] [Related]
15. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
16. Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9.
Zhang S; Wu L; Liu Q; Chen K; Zhang X
Onco Targets Ther; 2015; 8():223-31. PubMed ID: 25653543
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer.
Lin HY; Yu CC; Chi CL; Wei CK; Yin WY; Tseng CE; Li SC
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627159
[TBL] [Abstract][Full Text] [Related]
18. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
19. The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
Nagai T; Matsueda Y; Tomita T; Yoshikawa H; Hirohata S
Clin Exp Rheumatol; 2018; 36(2):248-253. PubMed ID: 29148420
[TBL] [Abstract][Full Text] [Related]
20. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]